357 related articles for article (PubMed ID: 8746217)
21. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion.
Gonon AT; Erbas D; Bröijersén A; Valen G; Pernow J
Am J Physiol Heart Circ Physiol; 2004 May; 286(5):H1767-74. PubMed ID: 14693683
[TBL] [Abstract][Full Text] [Related]
22. Myocardial release of nitric oxide during ischaemia and reperfusion: effects of L-arginine and hypercholesterolaemia.
Prasan AM; McCarron HC; Zhang Y; Jeremy RW
Heart Lung Circ; 2007 Aug; 16(4):274-81. PubMed ID: 17420156
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide fails to confer endogenous antiarrhythmic cardioprotection in the primate heart in vitro.
Pabla R; Curtis MJ
Br J Pharmacol; 2007 Apr; 150(7):893-8. PubMed ID: 17293889
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and prostacyclin modulate the alterations in cardiac action potential duration mediated by platelets during ischaemia.
Goulielmos NV; Enayat ZE; Sheridan DJ; Cohen H; Flores NA
Cardiovasc Res; 1995 Nov; 30(5):788-98. PubMed ID: 8595628
[TBL] [Abstract][Full Text] [Related]
25. Resveratrol provides late-phase cardioprotection by means of a nitric oxide- and adenosine-mediated mechanism.
Bradamante S; Barenghi L; Piccinini F; Bertelli AA; De Jonge R; Beemster P; De Jong JW
Eur J Pharmacol; 2003 Mar; 465(1-2):115-23. PubMed ID: 12650840
[TBL] [Abstract][Full Text] [Related]
26. L-arginine enhances functional recovery and Ca(2+)-dependent nitric oxide synthase activity after ischemia and reperfusion in the rat heart.
Wang QD; Morcos E; Wiklund P; Pernow J
J Cardiovasc Pharmacol; 1997 Feb; 29(2):291-6. PubMed ID: 9057081
[TBL] [Abstract][Full Text] [Related]
27. The effects of nitric oxide synthase--versus lipoxygenase inhibition on coronary flow and nitrite outflow in isolated rat heart.
Jakovljevic VLj; Djuric DM
Gen Physiol Biophys; 2005 Jun; 24(2):199-207. PubMed ID: 16118472
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase inhibition converts the effect of nitric oxide synthase inhibition from infarct size reduction to expansion in isolated rabbit hearts.
Aitchison KA; Coker SJ
J Mol Cell Cardiol; 1999 Jun; 31(6):1315-24. PubMed ID: 10371705
[TBL] [Abstract][Full Text] [Related]
29. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart.
Pabla R; Curtis MJ
Circ Res; 1995 Nov; 77(5):984-92. PubMed ID: 7554153
[TBL] [Abstract][Full Text] [Related]
30. Bradykinin-induced release of nitric oxide by the isolated perfused rat heart: importance of preformed pools of nitric oxide-containing factors.
Danser AH; de Vries R; Schoemaker RG; Saxena PR
J Hypertens; 1998 Feb; 16(2):239-44. PubMed ID: 9535152
[TBL] [Abstract][Full Text] [Related]
31. Coronary venous drug infusion in the ischaemic-reperfused isolated rat heart.
Uriuda Y; Wang QD; Li XS; Sjoquist PO; Nordlander R; Ryden L
Cardiovasc Res; 1996 Jan; 31(1):82-92. PubMed ID: 8849592
[TBL] [Abstract][Full Text] [Related]
32. The nucleotide metabolism in lactate perfused hearts under ischaemic and reperfused conditions.
de Groot MJ; Coumans WA; van der Vusse GJ
Mol Cell Biochem; 1992 Dec; 118(1):1-14. PubMed ID: 1488052
[TBL] [Abstract][Full Text] [Related]
33. EDRF does not mediate coronary vasodilation secondary to simulated ischemia: a study on KATP channels and N omega-nitro-L-arginine on coronary perfusion pressure in isolated Langendorff-perfused guinea-pig hearts.
Gasser R; Köppel H; Brussee H; Grisold M; Holzmann S; Klein W
Cardiovasc Drugs Ther; 1998 Jul; 12(3):279-84. PubMed ID: 9784907
[TBL] [Abstract][Full Text] [Related]
34. L-arginine reverses low coronary reflow and enhances postischaemic recovery of cardiac mechanical function.
Amrani M; Chester AH; Jayakumar J; Schyns CJ; Yacoub MH
Cardiovasc Res; 1995 Aug; 30(2):200-4. PubMed ID: 7585806
[TBL] [Abstract][Full Text] [Related]
35. Effects of landiolol on mechanical and metabolic changes in rat reperfused ischaemic hearts.
Sakanashi M; Sakanashi M; Sugahara K; Sakanashi M
Clin Exp Pharmacol Physiol; 2007; 34(1-2):55-60. PubMed ID: 17201736
[TBL] [Abstract][Full Text] [Related]
36. Attenuation of coronary autoregulation in the isolated rabbit heart by endothelium derived nitric oxide.
Pohl U; Lamontagne D; Bassenge E; Busse R
Cardiovasc Res; 1994 Mar; 28(3):414-9. PubMed ID: 8174163
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats.
Avontuur JA; Bruining HA; Ince C
Circ Res; 1995 Mar; 76(3):418-25. PubMed ID: 7532118
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of nitric oxide synthesis by NG-nitro-L-arginine methyl ester (L-NAME): requirement for bioactivation to the free acid, NG-nitro-L-arginine.
Pfeiffer S; Leopold E; Schmidt K; Brunner F; Mayer B
Br J Pharmacol; 1996 Jul; 118(6):1433-40. PubMed ID: 8832069
[TBL] [Abstract][Full Text] [Related]
39. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
[TBL] [Abstract][Full Text] [Related]
40. Fantofarone (SR 33557): effect on post-ischaemic functional recovery in perfused rat hearts.
Manning A; Mouton J; Chatelain P
Eur J Pharmacol; 1992 Sep; 220(2-3):249-58. PubMed ID: 1425996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
